141 related articles for article (PubMed ID: 25327347)
21. No evidence for IL1RAPL1 involvement in selected high-risk autism pedigrees from the AGRE data set.
Allen-Brady K; Cai G; Cannon D; Robison R; McMahon WM; Coon H; Buxbaum JD
Autism Res; 2011 Aug; 4(4):293-6. PubMed ID: 21491612
[TBL] [Abstract][Full Text] [Related]
22. Role of perfumes in pathogenesis of autism.
Bagasra O; Golkar Z; Garcia M; Rice LN; Pace DG
Med Hypotheses; 2013 Jun; 80(6):795-803. PubMed ID: 23578362
[TBL] [Abstract][Full Text] [Related]
23. [Autism spectrum disorders--a syndrome on the rise: risk factors and advances in early detection and intervention].
Zachor DA
Harefuah; 2012 Mar; 151(3):162-4, 189. PubMed ID: 22519265
[TBL] [Abstract][Full Text] [Related]
24. Neuronal connectivity as a convergent target of gene × environment interactions that confer risk for Autism Spectrum Disorders.
Stamou M; Streifel KM; Goines PE; Lein PJ
Neurotoxicol Teratol; 2013; 36():3-16. PubMed ID: 23269408
[TBL] [Abstract][Full Text] [Related]
25. Cochrane review: social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD).
Reichow B; Steiner AM; Volkmar F
Evid Based Child Health; 2013 Mar; 8(2):266-315. PubMed ID: 23877884
[TBL] [Abstract][Full Text] [Related]
26. Autism and nutrition: the role of the gut-brain axis.
van De Sande MM; van Buul VJ; Brouns FJ
Nutr Res Rev; 2014 Dec; 27(2):199-214. PubMed ID: 25004237
[TBL] [Abstract][Full Text] [Related]
27. Fine mapping of Xq11.1-q21.33 and mutation screening of RPS6KA6, ZNF711, ACSL4, DLG3, and IL1RAPL2 for autism spectrum disorders (ASD).
Kantojärvi K; Kotala I; Rehnström K; Ylisaukko-Oja T; Vanhala R; von Wendt TN; von Wendt L; Järvelä I
Autism Res; 2011 Jun; 4(3):228-33. PubMed ID: 21384559
[TBL] [Abstract][Full Text] [Related]
28. Etiologies underlying sex differences in Autism Spectrum Disorders.
Schaafsma SM; Pfaff DW
Front Neuroendocrinol; 2014 Aug; 35(3):255-71. PubMed ID: 24705124
[TBL] [Abstract][Full Text] [Related]
29. [Genetic factors in Asperger syndrome].
Sasaki T
Nihon Rinsho; 2007 Mar; 65(3):443-8. PubMed ID: 17354555
[TBL] [Abstract][Full Text] [Related]
30. Autism spectrum disorders: molecular genetic advances.
Bacchelli E; Maestrini E
Am J Med Genet C Semin Med Genet; 2006 Feb; 142C(1):13-23. PubMed ID: 16419096
[TBL] [Abstract][Full Text] [Related]
31. Major contribution of dominant inheritance to autism spectrum disorders (ASDs) in population-based families.
Nishiyama T; Notohara M; Sumi S; Takami S; Kishino H
J Hum Genet; 2009 Dec; 54(12):721-6. PubMed ID: 19893580
[TBL] [Abstract][Full Text] [Related]
32. A familial heterozygous null mutation of MET in autism spectrum disorder.
Lambert N; Wermenbol V; Pichon B; Acosta S; van den Ameele J; Perazzolo C; Messina D; Musumeci MF; Dessars B; De Leener A; Abramowicz M; Vilain C
Autism Res; 2014 Oct; 7(5):617-22. PubMed ID: 24909855
[TBL] [Abstract][Full Text] [Related]
33. Is autism curable?
Bölte S
Dev Med Child Neurol; 2014 Oct; 56(10):927-31. PubMed ID: 24840630
[TBL] [Abstract][Full Text] [Related]
34. Uncovering the etiology of autism spectrum disorders: genomics, bioinformatics, environment, data collection and exploration, and future possibilities.
Pendergrass S; Girirajan S; Selleck S
Pac Symp Biocomput; 2014; ():422-6. PubMed ID: 24297568
[TBL] [Abstract][Full Text] [Related]
35. Autism spectrum disorders revisited. Several recent studies raise new questions about cause and prevention.
Harv Ment Health Lett; 2011 Oct; 28(4):1-3. PubMed ID: 22125823
[No Abstract] [Full Text] [Related]
36. Genetic testing for autism spectrum disorders.
Bauer SC; Msall ME
Dev Disabil Res Rev; 2011; 17(1):3-8. PubMed ID: 22447748
[TBL] [Abstract][Full Text] [Related]
37. Autism spectrum disorders: the quest for genetic syndromes.
Zafeiriou DI; Ververi A; Dafoulis V; Kalyva E; Vargiami E
Am J Med Genet B Neuropsychiatr Genet; 2013 Jun; 162B(4):327-66. PubMed ID: 23650212
[TBL] [Abstract][Full Text] [Related]
38. Dietary interventions in children with autism spectrum disorders - an updated review of the research evidence.
Marti LF
Curr Clin Pharmacol; 2014; 9(4):335-49. PubMed ID: 24050740
[TBL] [Abstract][Full Text] [Related]
39. Using mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactions.
Schwartzer JJ; Koenig CM; Berman RF
Neurotoxicol Teratol; 2013; 36():17-35. PubMed ID: 23010509
[TBL] [Abstract][Full Text] [Related]
40. [Genes, environment and autism spectrum disorders].
Staal W
Tijdschr Psychiatr; 2014; 56(10):668-9. PubMed ID: 25327348
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
